Literature DB >> 20207012

Being homebound with chronic fatigue syndrome: A multidimensional comparison with outpatients.

Jan F Wiborg1, Sieberen van der Werf, Judith B Prins, Gijs Bleijenberg.   

Abstract

Many patients with chronic fatigue syndrome (CFS) seem to experience periods in which they are homebound due to their symptomatology. Despite a growing body of research about CFS, little is known about patients who no longer feel able to leave their homes. The purpose of the present study was to examine whether homebound patients differ from other CFS patients on illness-specific characteristics. Besides experiencing more impairment in daily functioning than participants of an outpatient intervention study, homebound patients were characterised by extremely high levels of daily fatigue, predominant somatic attributions, and pervasively passive activity patterns. The course of symptomatology was similarly stable in both groups. Our findings suggest that homebound patients form a distinct subgroup of CFS patients who might profit from a treatment approach that is tailored to their specific needs. The exploratory nature of this first systematic investigation of homebound CFS patients is stressed, and suggestions for future research are made. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20207012     DOI: 10.1016/j.psychres.2010.02.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Neurocognitive complaints and functional status among patients with chronic fatigue syndrome and fibromyalgia.

Authors:  Karen B Schmaling; Karran L Betterton
Journal:  Qual Life Res       Date:  2015-10-15       Impact factor: 4.147

2.  Telephone-administered versus live group cognitive behavioral stress management for adults with CFS.

Authors:  Daniel L Hall; Emily G Lattie; Sara F Milrad; Sara Czaja; Mary Ann Fletcher; Nancy Klimas; Dolores Perdomo; Michael H Antoni
Journal:  J Psychosom Res       Date:  2016-12-08       Impact factor: 3.006

3.  Clinical Criteria Versus a Possible Research Case Definition in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Authors:  Leonard A Jason; Stephanie McManimen; Madison Sunnquist; Julia L Newton; Elin Bolle Strand
Journal:  Fatigue       Date:  2017-03-06

4.  Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome.

Authors:  Tricia Pendergrast; Abigail Brown; Madison Sunnquist; Rachel Jantke; Julia L Newton; Elin Bolle Strand; Leonard A Jason
Journal:  Chronic Illn       Date:  2016-04-28

5.  Natural killer cells in patients with severe chronic fatigue syndrome.

Authors:  E W Brenu; S L Hardcastle; G M Atkinson; M L van Driel; S Kreijkamp-Kaspers; K J Ashton; D R Staines; S M Marshall-Gradisnik
Journal:  Auto Immun Highlights       Date:  2013-04-16

6.  Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

Authors:  Sharni Lee Hardcastle; Ekua Weba Brenu; Samantha Johnston; Thao Nguyen; Teilah Huth; Naomi Wong; Sandra Ramos; Donald Staines; Sonya Marshall-Gradisnik
Journal:  BMC Immunol       Date:  2015-06-02       Impact factor: 3.615

7.  Adult patients' experiences of NHS specialist services for chronic fatigue syndrome (CFS/ME): a qualitative study in England.

Authors:  Jessica Broughton; Sarah Harris; Lucy Beasant; Esther Crawley; Simon M Collin
Journal:  BMC Health Serv Res       Date:  2017-06-02       Impact factor: 2.655

Review 8.  Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected.

Authors:  Patricia A Fennell; Nancy Dorr; Shane S George
Journal:  Healthcare (Basel)       Date:  2021-05-09

Review 9.  Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Lily Chu; Meghan Elliott; Eleanor Stein; Leonard A Jason
Journal:  Healthcare (Basel)       Date:  2021-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.